Results for the First Half of the 2020-2021 Financial Year

6% at actual rates. (+1% at a constant exchange rate). After a decline in activity in the first quarter of 2020-2021, due to the impact of the ... Backtoposts 11March2021 ResultsfortheFirstHalfofthe2020-2021FinancialYear ContinuedTransformationandDevelopment ACTIVITY Salesforthefirsthalfoftheyearcameto€402.3million,up+4.2%atactualratescomparedwiththesameperiodlastyear(+4.7%atlikeforlikeexchangerate). Salesforthe“Fashion”businesscameto€297.8million,aslightincreaseof+.6%atactualrates.(+1%ataconstantexchangerate).Afteradeclineinactivityinthefirstquarterof2020-2021,duetotheimpactofthehealthcrisisandrestrictivemeasures,thedivisionrecordedasharpreboundinthesecondquarter(+2.6%atactualrates).Thismomentumobservedinthefirsthalfoftheyear,wasdriveninparticularbytheDamartbrand(+1.5%atactualrates)mainlyduetotheexcellentperformanceofmailorder.The“Home&Lifestyle”businesscontinuedtogrowatadynamicrateof+12.2%atactualrates(+13.0%atlikeforlikeexchangerate)for€89.1Mnofturnover.Thedivisionalsoreturnedtoexcellentmomentuminthesecondquarter(+14.4%atactualrates)drivenbythefavourablereceptiongiventotherenewedCoopersofStortfordrange,aswellasstronggrowthinthe3PagenandVitrineMagiquebrands. Finally,therecentlycreated“Healthcare”division,dedicatedtohealthcareactivities,confirmeditsobjectiveswithanincreaseof+47.3%atactualrates(+48.1%atlikeforlikeexchangerate)withaturnoverof€15.4million.Thisgrowthissupportedbythetwobrandsthatmakeupthedivision:Santéol(integratedin2020)andSedagyl. RESULTS TheoperatingEBITDAclosedwithasignificantincreaseto€26.6Mn(comparedwith€11.5millioninthepreviousfinancialyear).Thisperformanceisexplainedbythereboundinactivityrecordedmainlyinthesecondquarterof2020,combinedwithacarefulpolicyofcostcontrol,particularlyinmarketing,inordertoprudentlyaddressadeterioratedmarketenvironment. Thecurrentoperatingincome(so-calledROC)thereforeshowsstronggrowthat€15.3million(comparedwith€2.4millioninthepreviousfinancialyear).Thisperformanceappliestoallthe“Fashion”,“Home&Lifestyle”and“Healthcare”divisions,withaROCof€8.5Mn,€5.4Mnand€1.4Mnrespectively.Netearningsstandat€11.1Mn(comparedwith€1.9Mnforthepreviousfinancialyear). Damartexthusreturnedtoagoodlevelofprofitabilityinthefirsthalfoftheyear,confirmingthetrendinitiatedinthe2019financialyear. FINANCIALPOSITION Thenetfinancialpositionstandsat€+17.9Mn(against€-42.5millioninthepreviousfinancialyear).Thisincreaseistheresultofthegrowthinactivityandismainlybasedontwolevers: thetakingintoaccountoftheexceptionalcapitalincreaseof€33.9million;and theexcellentmanagementofworkingcapitalrequirements(€-9.9Mncomparedto€31.8Mnin2019)despiteanextremelyvolatileenvironmentduetothehealthcrisis.Thisperformanceisthedirectconsequenceoftheeffortsundertakeninaxis4ofthetransformationplan(prioritytoagility). TheGroup’sfinancialstrengthenablesittoaccelerateitstransformationplanandpursueanopportunisticexternalgrowthpolicyinlinewithitsdevelopmentambitionsintheSilverEconomymarket. OUTLOOK Thiscommercialperformance,despitethehealthcrisiscontext,combinedwithareinforcedfinancialsoundness,aresolidassetstoaddressthefuture.DamartexisthusproactivelypursuingthedeploymentofitsTTA2.0transformationplan,particularlyonthedigitalizationaspects,enablingittoaddressthechallengesoftheSilverEconomymarket.However,theGroupremainscautiousinviewoftheremaininguncertaintiesrelatedtothenovelcoronavirusepidemic Share Otherposts 29April2022 AcquisitionoftheMédicalSantéGroup Furtherdevelopmentinthe“Healthcare”sectorandrestructuringofthehomecare(MAD)activityAspartofits‘TransformToAccelerate–TTA2.0’transformationplan,theDamartexgroupannounceditsacquisitionof100%ofthesharesintheMédicalSantégroup,therebyreinforcingitspositionasaEuropeanleaderintheSilverEconomy.Createdin[…] Readmore 29April2022 TurnoveroftheFirstNineMonthsofthe2021/2022FinancialYear ContinuationoftheGroup’sTransformationPlanDespiteanUncertainandInflationaryEnvironmentDamartexclosedthethirdquarterwithsalesof€173.0Mn,down-11.3%atactualexchangerates(down-12.5%atlikeforlikeexchangerates)comparedwiththethirdquarterofthepreviousfinancialyear.TheGroup’sbusinessissufferingfromrecordinflation,[…] Readmore 9March2022 AcquisitionofthecompanyJPConsult TheDamartexgroupannouncestheacquisitionof100%ofthesharesofthecompanyJPConsultbythecompanySantéolHolding.Thisoperation,likethatofPerfRinÎledeFrancerecently,ispartofthegroup’stransformationplan:“TransformToAccelerate–TTA2.0”.JPConsultisahomehealthcareprovider(PSAD)[…] Readmore 1March2022 AcquisitionofthecompanyPERFR Aspartofits“TransformToAccelerate–TTA2.0”transformationplan,theDamartexgroupannouncestheacquisitionof100%ofthesharesofthecompanyPerfRbythecompanySantéolîledeFrance.ThecompanyPerfR,ahomehealthcareproviderspecialisinginrespiratoryassistance,isbasedinPalaiseauinIle-de-France.Perf[…] Readmore 18February2022 XandresenterstheGermanmarket DamartexexpandsitsgeographicalcoveragewiththelaunchofXandres,itsaffordableluxurybrandontheGermanmarket.XandresisaleadingBelgianfashionbrand,synonymouswithqualityandattentiontodetail,andisalreadypresentinBelgium,LuxembourgandtheNetherlands.TheXandrescollectionsaredesignedforwomenwhoappreciateclassicandtimelessfashion,[…] Readmore 30November2021 DamartexconcludesanewacquisitionforitsHealthcaredivision,withOptimumMédical OngoingdevelopmentoftheHealthcaredivisionAspartofitstransformationplan“TransformToAccelerate–TTA2.0”,Damartexgroupannouncestheacquisitionof100%ofthesharesofOptimumMédicalbytheholdingcompanyMSanté.MSantéwasacquiredbyDamartexinJuly2021toexpanditsHealthcaredivisionintheinfusionandnutritionsectors.OptimumMédical,basedinthe[…] Readmore 9September2021 Resultsforthe2020-2021financialyear AStrongFinancialPerformanceHelpingAcceleratetheTransformationACTIVITYTheDamartexGroupclosesthe2020/2021financialyearwithaturnoverof€764.2million,up11.4%atrealexchangeratescomparedtothepreviousfinancialyear,thankstoadefiniterecoveryinactivitydrivenbytheeffectsofthetransformationplaninitiatedbytheGroup,despite[…] Readmore 22July2021 Turnoverofthe2020-2021FinancialYear AccelerationofBusinessinLinewiththeTransformationPlanForthe2020/21financialyear,theGroup’ssalesamountedto€764.2Mn,anincreaseof+11.4%atactualratescomparedwiththepreviousfinancialyear(+11.6%atlikeforlikeexchangerates).Afteranupwardtrendinthefirsthalfoftheyear,thesecond[…] Readmore 22July2021 DamartexStrengthensitsHealthcareDivisionwiththeAcquisitionofMSanté Aspartofitstransformationplan,“TransformToAccelerate–TTA2.0”,theDamartexgroupannouncestheacquisitionof80.0%ofthesharesofMSantébyDamartexS.A.MSantéisahomehealthcareserviceprovider(so-calledPSAD),specializingininfusionandnutrition.Itwascreatedin2013byStéphaneFreche,whoremainsashareholderin[…] Readmore